Point of Care (PoC) Molecular Diagnostics Market Size By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Sep 2020  |  Report ID: GMI2210  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 140   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1.  Secondary

1.4.1.1.    Paid sources

1.4.1.2.    Unpaid sources

1.4.2.  Primary

Chapter 2. Executive Summary

2.1. Point of care molecular diagnostics industry 3600 synopsis, 2015 - 2026

2.1.1.  Business trends

2.1.2.  Technology trends

2.1.3.  Application trends

2.1.4.  End-use trends

2.1.5.  Regional trends

Chapter 3. Point of Care Molecular Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.  Growth drivers

3.3.1.1. Increasing incidence of infectious diseases in developed and developing economies

3.3.1.2. Increasing R&D funding to reduce time required for molecular diagnostic tests

3.3.1.3. Growing awareness in developing countries about pre-disease diagnostics to control occurrence of diseases

3.3.1.4. Technological advancements in DNA sequencing and analysis

3.3.2.  Industry pitfalls and challenges

3.3.2.1. Long product development time

3.3.2.2. Complex regulatory process

3.4. Growth potential analysis

3.4.1.  By technology

3.4.2.  By application

3.4.3.  By end-use

3.5. COVID-19 impact analysis

3.6. Technology landscape

3.7. All in one diagnostics solutions overview

3.8. Porter’s analysis

3.9. Competitive landscape, 2019

3.10.  PESTEL Analysis

Chapter 4. Point of Care Molecular Diagnostics Market, By Technology

4.1. Key segment trends

4.2. PCR

4.2.1.  PCR market, by region, 2015 - 2026, (USD Million)

4.3. In situ hybridization

4.3.1.  In situ hybridization market, by region, 2015 - 2026, (USD Million)

4.4. Sequencing

4.4.1.  Sequencing market, by region, 2015 - 2026, (USD Million)

4.5. Isothermal amplification

4.5.1.  Isothermal amplification market, by region, 2015 - 2026, (USD Million)

4.6. Others

4.6.1.  Others market, by region, 2015 - 2026, (USD Million)

Chapter 5. Point of Care Molecular Diagnostics Market, By Application

5.1. Key segment trends

5.2. Infectious disease

5.2.1.  Infectious disease market by region, 2015 - 2026 (USD Million)

5.2.2.  Flu

5.2.2.1.  Flu market, by region, 2015 - 2026 (USD Million)

5.2.3.  Tuberculosis

5.2.3.1.  Tuberculosis market, by region, 2015 - 2026 (USD Million)

5.2.4.  HIV

5.2.4.1.  HIV market, by region, 2015 - 2026 (USD Million)

5.2.5.  Gonorrhea

5.2.5.1.  Gonorrhea market, by region, 2015 - 2026 (USD Million)

5.2.6.  Chlamydia

5.2.6.1.  Chlamydia market, by region, 2015 - 2026 (USD Million)

5.2.7.  Hepatitis C

5.2.7.1.  Hepatitis C market, by region, 2015 - 2026 (USD Million)

5.2.8.  Hepatitis B

5.2.8.1.  Hepatitis B market, by region, 2015 - 2026 (USD Million)

5.2.9.  Others

5.2.9.1.  Others market, by region, 2015 - 2026 (USD Million)

5.3. Oncology

5.3.1.  Oncology market, by region, 2015 - 2026 (USD Million)

5.4. Hematology

5.4.1.  Hematology market, by region, 2015 - 2026 (USD Million)

5.5. Others

5.5.1.  Others market, by region, 2015 - 2026 (USD Million)

Chapter 6. Point of Care Molecular Diagnostics Market, By End-use

6.1. Key segment trends

6.2. Hospitals

6.2.1.  Hospitals market, by region, 2015 - 2026 (USD Million)

6.3. Clinics

6.3.1.  Clinics market, by region, 2015 - 2026 (USD Million)

6.4. Others

6.4.1.  Others market, by region, 2015 - 2026 (USD Million)

Chapter 7. Point of Care Molecular Diagnostics Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1.   North America point of care molecular diagnostics market, by country, 2015 - 2026 (USD Million)

7.2.2.   North America point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.2.3.   North America point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.2.3.1.  North America point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.2.4.   North America point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.2.5.  U.S.

7.2.5.1.  U.S. point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.2.5.2.  U.S. point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.2.5.2.1.  U.S. point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.2.5.3.  U.S. point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.2.6.  Canada

7.2.6.1.  Canada point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.2.6.2.  Canada point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.2.6.2.1.  Canada point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.2.6.3.  Canada point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3. Europe

7.3.1.   Europe point of care molecular diagnostics market, by country, 2015 - 2026 (USD Million)

7.3.2.   Europe point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.3.   Europe point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.3.1.  Europe point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.4.  Europe point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3.5.  Germany

7.3.5.1.  Germany point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.5.2.  Germany point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.5.2.1.  Germany point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.5.3.  Germany point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3.6.  UK

7.3.6.1.  UK point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.6.2.  UK point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.6.2.1.  UK point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.6.3.  UK point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3.7.  France

7.3.7.1.  France point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.7.2.  France point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.7.2.1.  France point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.7.3.  France point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3.8.  Italy

7.3.8.1.  Italy point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.8.2.  Italy point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.8.2.1.  Italy point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.8.3.  Italy point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3.9.  Spain

7.3.9.1.  Spain point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.9.2.  Spain point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.9.2.1.  Spain point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.9.3.  Spain point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.3.10.  Russia

7.3.10.1.  Russia point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.3.10.2.  Russia point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.3.10.2.1.  Russia point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.3.10.3.  Russia point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4. Asia Pacific

7.4.1.  Asia Pacific point of care molecular diagnostics market, by country, 2015 - 2026 (USD Million)

7.4.2.  Asia Pacific point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.3.  Asia Pacific point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.3.1.  Asia Pacific point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.4.  Asia Pacific point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.5.  Japan

7.4.5.1.  Japan point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.5.2.  Japan point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.5.2.1.  Japan point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.5.3.  Japan point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.6.  China

7.4.6.1.  China point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.6.2.  China point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.6.2.1.  China point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.6.3.  China point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.7.  India

7.4.7.1.  India point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.7.2.  India point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.7.2.1.  India point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.7.3.  India point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.8.  South Korea

7.4.8.1.  South Korea point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.8.2.  South Korea point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.8.2.1.  South Korea point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.8.3.  South Korea point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.9.  Malaysia

7.4.9.1.  Malaysia point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.9.2.  Malaysia point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.9.2.1.  Malaysia point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.9.3.  Malaysia point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.10.  Thailand

7.4.10.1.  Thailand point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.10.2.  Thailand point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.10.2.1.  Thailand point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.10.3.  Thailand point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.11.  Vietnam

7.4.11.1.  Vietnam point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.11.2.  Vietnam point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.11.2.1.  Vietnam point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.11.3.  Vietnam point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.12.  Philippines

7.4.12.1.  Philippines point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.12.2.  Philippines point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.12.2.1.  Philippines point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.12.3.  Philippines point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.4.13.  Australia

7.4.13.1.  Australia point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.4.13.2.  Australia point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.4.13.2.1.  Australia point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.4.13.3.  Australia point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.5. Latin America

7.5.1.  Latin America point of care molecular diagnostics market, by country, 2015 - 2026 (USD Million)

7.5.2.  Latin America point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.5.3.  Latin America point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.5.3.1.  Latin America point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.5.4.  Latin America point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.5.5.  Brazil

7.5.5.1.  Brazil point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.5.5.2.  Brazil point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.5.5.2.1.  Brazil point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.5.5.3.  Brazil point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.5.6.  Argentina

7.5.6.1.  Argentina point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.5.6.2.  Argentina point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.5.6.2.1.  Argentina point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.5.6.3.  Argentina point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.5.7.  Mexico

7.5.7.1.  Mexico point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.5.7.2.  Mexico point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.5.7.2.1.  Mexico point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.5.7.3.  Mexico point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6. MEA

7.6.1.   MEA point of care molecular diagnostics market, by country, 2015 - 2026 (USD Million)

7.6.2.   MEA point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.3.  MEA point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.3.1.  MEA point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.4.  MEA point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6.5.  South Africa

7.6.5.1.  South Africa point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.5.2.  South Africa point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.5.2.1.  South Africa point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.5.3.  South Africa point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6.6.  Nigeria

7.6.6.1.  Nigeria point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.6.2.  Nigeria point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.6.2.1.  Nigeria point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.6.3.  Nigeria point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6.7.  Egypt

7.6.7.1.  Egypt point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.7.2.  Egypt point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.7.2.1.  Egypt point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.7.3.  Egypt point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6.8.  Morocco

7.6.8.1.  Morocco point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.8.2.  Morocco point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.8.2.1.  Morocco point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.8.3.  Morocco point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6.9.  Saudi Arabia

7.6.9.1.  Saudi Arabia point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.9.2.  Saudi Arabia point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.9.2.1.  Saudi Arabia point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.9.3.  Saudi Arabia point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

7.6.10.          UAE

7.6.10.1.  UAE point of care molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

7.6.10.2.  UAE point of care molecular diagnostics market, by application, 2015 - 2026 (USD Million)

7.6.10.2.1.     UAE point of care molecular diagnostics market, by infectious disease, 2015 - 2026 (USD Million)

7.6.10.3.  UAE point of care molecular diagnostics market, by end-use, 2015 - 2026 (USD Million)

Chapter 8. Company Profiles

8.1. Strategy Dashboard, 2019

8.2. Abaxis Inc.

8.2.1.  Business Overview

8.2.2.  Financial data

8.2.3.  Product landscape

8.2.4.  Strategic outlook

8.2.5.  SWOT analysis

8.3. Abbott Laboratories

8.3.1.  Business overview

8.3.2.  Financial data

8.3.3.  Product landscape

8.3.4.  Strategic outlook

8.3.5.  SWOT analysis

8.4. BioMérieux SA

8.4.1.  Business overview

8.4.2.  Financial data

8.4.3.  Product landscape

8.4.4.  Strategic outlook

8.4.5.  SWOT analysis

8.5. Bio-Rad Laboratories

8.5.1.  Business overview

8.5.2.  Financial Data

8.5.3.  Product landscape

8.5.4.  Strategic outlook

8.5.5.  SWOT analysis

8.6. Danaher Corporation

8.6.1.  Business overview

8.6.2.  Financial data

8.6.3.  Product landscape

8.6.4.  SWOT analysis

8.7. F. Hoffmann-La Roche Ltd

8.7.1.  Business overview

8.7.2.  Financial data

8.7.3.  Product landscape

8.7.4.  Strategic outlook

8.7.5.  SWOT analysis

8.8. Siemens Healthcare GmbH

8.8.1.  Business overview

8.8.2.  Financial data

8.8.3.  Product landscape

8.8.4.  SWOT analysis

8.9. Sysmex Corporation

8.9.1.  Business overview

8.9.2.  Financial data

8.9.3.  Product landscape

8.9.4.  SWOT analysis

8.10.  VIRCELL S.L

8.10.1. Business overview

8.10.2. Financial data

8.10.3. Product landscape

8.10.4. SWOT analysis

8.11.  Mesa Biotech

8.11.1. Business overview

8.11.2. Financial data

8.11.3. Product landscape

8.11.4. Strategic outlook

8.11.5. SWOT analysis

 

Data Tables

TABLE 1.     PoC molecular diagnostics industry 360° synopsis, 2015 - 2026

TABLE 2.     PoC molecular diagnostics market, 2015 - 2026 (USD Million)

TABLE 3.     PoC molecular diagnostics market, by technology, 2015 - 2026 (USD Million)

TABLE 4.     PoC molecular diagnostics market, by application, 2015 - 2026 (USD Mn)

TABLE 5.     PoC molecular diagnostics market, by end-use, 2015 - 2026 (USD Mn)

TABLE 6.     PoC molecular diagnostics market, by region, 2015 - 2026 (USD Million)

TABLE 7.     Industry impact forces

TABLE 8.     Some of the major players in ‘all-in-one’ diagnostics industry

TABLE 9.     PCR (Polymerase Chain Reaction) market size, by region, 2015 - 2026 (USD Million)

TABLE 10.   In situ hybridization market size, by region, 2015 - 2026 (USD Million)

TABLE 11.   Sequencing market size, by region, 2015 - 2026 (USD Million)

TABLE 12.   Isothermal amplification market size, by region, 2015 - 2026 (USD Million)

TABLE 13.   Others market size, by region, 2015 - 2026 (USD Million)

TABLE 14.   Infectious disease market size, by region, 2015 - 2026 (USD Million)

TABLE 15.   Flu market size, by region, 2015 - 2026 (USD Million)

TABLE 16.   Respiratory syncytial virus (RSV) market size, by region, 2015 - 2026 (USD Million)

TABLE 17.   Tuberculosis (TB) market size, by region, 2015 - 2026 (USD Million)

TABLE 18.   Chlamydia market size, by region, 2015 - 2026 (USD Million)

TABLE 19.   Gonorrhea market size, by region, 2015 - 2026 (USD Million)

TABLE 20.   HIV market size, by region, 2015 - 2026 (USD Million)

TABLE 21.   Hepatitis C market size, by region, 2015 - 2026 (USD Million)

TABLE 22.   Hepatitis B market size, by region, 2015 - 2026 (USD Million)

TABLE 23.   Others market size, by region, 2015 - 2026 (USD Million)

TABLE 24.   Hospitals market size, by region, 2015 - 2026 (USD Million)

TABLE 25.   Clinics market size, by region, 2015 - 2026 (USD Million)

TABLE 26.   Others market size, by region, 2015 - 2026 (USD Million)

TABLE 27.   North America market size, by country, 2015 - 2026 (USD Million)

TABLE 28.   North America market size, by technology, 2015 - 2026 (USD Million)

TABLE 29.   North America market size, by application, 2015 - 2026 (USD Million)

TABLE 30.   North America market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 31.   North America market size, by end-use, 2015 - 2026 (USD Million)

TABLE 32.   U.S. market size, by technology, 2015 - 2026 (USD Million)

TABLE 33.   U.S. market size, by application, 2015 - 2026 (USD Million)

TABLE 34.   U.S. market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 35.   U.S. market size, by end-use, 2015 - 2026 (USD Million)

TABLE 36.   Canada market size, by technology, 2015 - 2026 (USD Million)

TABLE 37.   Canada market size, by application, 2015 - 2026 (USD Million)

TABLE 38.   Canada market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 39.   Canada market size, by end-use, 2015 - 2026 (USD Million)

TABLE 40.   Europe market size, by country, 2015 - 2026 (USD Million)

TABLE 41.   Europe market size, by technology, 2015 - 2026 (USD Million)

TABLE 42.   Europe market size, by application, 2015 - 2026 (USD Million)

TABLE 43.   Europe market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 44.   Europe market size, by end-use, 2015 - 2026 (USD Million)

TABLE 45.   Germany market size, by technology, 2015 - 2026 (USD Million)

TABLE 46.   Germany market size, by application, 2015 - 2026 (USD Million)

TABLE 47.   Germany market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 48.   Germany market size, by end-use, 2015 - 2026 (USD Million)

TABLE 49.   UK market size, by technology, 2015 - 2026 (USD Million)

TABLE 50.   UK market size, by application, 2015 - 2026 (USD Million)

TABLE 51.   UK market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 52.   UK market size, by end-use, 2015 - 2026 (USD Million)

TABLE 53.   France market size, by technology, 2015 - 2026 (USD Million)

TABLE 54.   France market size, by application, 2015 - 2026 (USD Million)

TABLE 55.   France market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 56.   France market size, by end-use, 2015 - 2026 (USD Million)

TABLE 57.   Spain market size, by technology, 2015 - 2026 (USD Million)

TABLE 58.   Spain market size, by application, 2015 - 2026 (USD Million)

TABLE 59.   Spain market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 60.   Spain market size, by end-use, 2015 - 2026 (USD Million)

TABLE 61.   Italy market size, by technology, 2015 - 2026 (USD Million)

TABLE 62.   Italy market size, by application, 2015 - 2026 (USD Million)

TABLE 63.   Italy market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 64.   Italy market size, by end-use, 2015 - 2026 (USD Million)

TABLE 65.   Russia market size, by technology, 2015 - 2026 (USD Million)

TABLE 66.   Russia market size, by application, 2015 - 2026 (USD Million)

TABLE 67.   Russia market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 68.   Russia market size, by end-use, 2015 - 2026 (USD Million

TABLE 69.   Asia Pacific market size, by country, 2015 - 2026 (USD Million)

TABLE 70.   Asia Pacific market size, by technology, 2015 - 2026 (USD Million)

TABLE 71.   Asia Pacific market size, by application, 2015 - 2026 (USD Million)

TABLE 72.   Asia Pacific market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 73.   Asia Pacific market size, by end-use, 2015 - 2026 (USD Million)

TABLE 74.   Japan market size, by technology, 2015 - 2026 (USD Million)

TABLE 75.   Japan market size, by application, 2015 - 2026 (USD Million)

TABLE 76.   Japan market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 77.   Japan market size, by end-use, 2015 - 2026 (USD Million)

TABLE 78.   China market size, by technology, 2015 - 2026 (USD Million)

TABLE 79.   China market size, by application, 2015 - 2026 (USD Million)

TABLE 80.   China market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 81.   China market size, by end-use, 2015 - 2026 (USD Million)

TABLE 82.   India market size, by technology, 2015 - 2026 (USD Million)

TABLE 83.   India market size, by application, 2015 - 2026 (USD Million)

TABLE 84.   India market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 85.   India market size, by end-use, 2015 - 2026 (USD Million)

TABLE 86.   South Korea market size, by technology, 2015 - 2026 (USD Million)

TABLE 87.   South Korea market size, by application, 2015 - 2026 (USD Million)

TABLE 88.   South Korea market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 89.   South Korea market size, by end-use, 2015 - 2026 (USD Million)

TABLE 90.   Malaysia market size, by technology, 2015 - 2026 (USD Million)

TABLE 91.   Malaysia market size, by application, 2015 - 2026 (USD Million)

TABLE 92.   Malaysia market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 93.   Malaysia market size, by end-use, 2015 - 2026 (USD Million)

TABLE 94.   Thailand market size, by technology, 2015 - 2026 (USD Million)

TABLE 95.   Thailand market size, by application, 2015 - 2026 (USD Million)

TABLE 96.   Thailand market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 97.   Thailand market size, by end-use, 2015 - 2026 (USD Million)

TABLE 98.   Vietnam market size, by technology, 2015 - 2026 (USD Million)

TABLE 99.   Vietnam market size, by application, 2015 - 2026 (USD Million)

TABLE 100. Vietnam market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 101. Vietnam market size, by end-use, 2015 - 2026 (USD Million)

TABLE 102. Philippines market size, by technology, 2015 - 2026 (USD Million)

TABLE 103. Philippines market size, by application, 2015 - 2026 (USD Million)

TABLE 104. Philippines market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 105. Philippines market size, by end-use, 2015 - 2026 (USD Million)

TABLE 106. Australia market size, by technology, 2015 - 2026 (USD Million)

TABLE 107. Australia market size, by application, 2015 - 2026 (USD Million)

TABLE 108. Australia market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 109. Australia market size, by end-use, 2015 - 2026 (USD Million)

TABLE 110. Latin America market size, by country, 2015 - 2026 (USD Million)

TABLE 111. Latin America market size, by technology, 2015 - 2026 (USD Million)

TABLE 112. Latin America market size, by application, 2015 - 2026 (USD Million)

TABLE 113. Latin America market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 114. Latin America market size, by end-use, 2015 - 2026 (USD Million)

TABLE 115. Brazil market size, by technology, 2015 - 2026 (USD Million)

TABLE 116. Brazil market size, by application, 2015 - 2026 (USD Million)

TABLE 117. Brazil market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 118. Brazil market size, by end-use, 2015 - 2026 (USD Million)

TABLE 119. Argentina market size, by technology, 2015 - 2026 (USD Million)

TABLE 120. Argentina market size, by application, 2015 - 2026 (USD Million)

TABLE 121. Argentina market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 122. Argentina market size, by end-use, 2015 - 2026 (USD Million)

TABLE 123. Mexico market size, by technology, 2015 - 2026 (USD Million)

TABLE 124. Mexico market size, by application, 2015 - 2026 (USD Million)

TABLE 125. Mexico market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 126. Mexico market size, by end-use, 2015 - 2026 (USD Million)

TABLE 127. MEA market size, by country, 2015 - 2026 (USD Million)

TABLE 128. MEA market size, by technology, 2015 - 2026 (USD Million)

TABLE 129. MEA market size, by application, 2015 - 2026 (USD Million)

TABLE 130. MEA market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 131. MEA market size, by end-use, 2015 - 2026 (USD Million)

TABLE 132. South Africa market size, by technology, 2015 - 2026 (USD Million)

TABLE 133. South Africa market size, by application, 2015 - 2026 (USD Million)

TABLE 134. South Africa market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 135. South Africa market size, by end-use, 2015 - 2026 (USD Million)

TABLE 136. Nigeria market size, by technology, 2015 - 2026 (USD Million)

TABLE 137. Nigeria market size, by application, 2015 - 2026 (USD Million)

TABLE 138. Nigeria market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 139. Nigeria market size, by end-use, 2015 - 2026 (USD Million)

TABLE 140. Egypt market size, by technology, 2015 - 2026 (USD Million)

TABLE 141. Egypt market size, by application, 2015 - 2026 (USD Million)

TABLE 142. Egypt market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 143. Egypt market size, by end-use, 2015 - 2026 (USD Million)

TABLE 144. Morocco market size, by technology, 2015 - 2026 (USD Million)

TABLE 145. Morocco market size, by application, 2015 - 2026 (USD Million)

TABLE 146. Morocco market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 147. Morocco market size, by end-use, 2015 - 2026 (USD Million)

TABLE 148. Saudi Arabia market size, by technology, 2015 - 2026 (USD Million)

TABLE 149. Saudi Arabia market size, by application, 2015 - 2026 (USD Million)

TABLE 150. Saudi Arabia market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 151. Saudi Arabia market size, by end-use, 2015 - 2026 (USD Million)

TABLE 152. UAE market size, by technology, 2015 - 2026 (USD Million)

TABLE 153. UAE market size, by application, 2015 - 2026 (USD Million)

TABLE 154. UAE market size, by infectious disease, 2015 - 2026 (USD Million)

TABLE 155. UAE market size, by end-use, 2015 - 2026 (USD Million)

 

Charts & Figures

FIG. 1   Industry segmentation

FIG. 2   Global PoC molecular diagnostics market, 2015 - 2026 (USD Million)

FIG. 3   Growth potential analysis, by technology

FIG. 4   Growth potential analysis, by application

FIG. 5   Growth potential analysis, by end-use

FIG. 6   Porter’s analysis

FIG. 7   Strategy dashboard, 2019

FIG. 8   PESTEL analysis
 

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Sep 2020
  • Pages: 140
  • Tables: 155
  • Charts / Figures: 8
  • Companies covered: 10
  • Countries covered: 26

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X